Panax red ginseng extract regulates energy expenditures by modulating PKA dependent lipid mobilization in adipose tissue

Biochemical and Biophysical Research Communications

Volumn 447, Issue 4, 2014, Pages 644-648

  Cho, Hae Mi ^a   Kang, Young Ho ^a   Yoo, Hanju ^a   Yoon, Seung Yong ^a   Kang, Sang Wook ^a   Chang, Eun Ju ^a   Song, Youngsup ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Adipose tissue; Energy expenditures; Obesity; Panax ginseng; Protein Kinase A

Indexed keywords

ANTIOBESITY AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; GINSENG EXTRACT;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CONTROLLED STUDY; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FLUID INTAKE; FOOD INTAKE; IN VIVO STUDY; LIPID METABOLISM; LIPOLYSIS; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

MUS; PANAX; PANAX GINSENG;

ADIPOSE TISSUE; ENERGY EXPENDITURES; OBESITY; PANAX GINSENG; PROTEIN KINASE A;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIET, HIGH-FAT; ENERGY METABOLISM; LIPID MOBILIZATION; MICE; MICE, INBRED C57BL; OBESITY; PANAX; PLANT EXTRACTS;

EID: 84900405928     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.056     Document Type: Article

References (23)

1. Y.J. Lee, E. Chung, K.Y. Lee, Y.H. Lee, B. Huh, and S.K. Lee Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor Mol. Cell. Endocrinol. 133 1997 135 140
2. K.W. Leung, F.P. Leung, Y. Huang, N.K. Mak, and R.N. Wong Non-genomic effects of ginsenoside-Re in endothelial cells via glucocorticoid receptor FEBS Lett. 581 2007 2423 2428
3. Z. Liu, L.J. Wang, X. Li, J.N. Hu, Y. Chen, C.C. Ruan, and G.Z. Sun Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice Phytother. Res. 23 2009 1426 1430
4. Q.N. Tu, H. Dong, and F.E. Lu Effects of Panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus Chin. J. Integr. Med. 17 2011 612 615
5. T. Yokozawa, T. Yasui, and H. Oura Molecular biological analysis of the effects of ginsenoside-Rb2 on albumin mRNA in streptozotocin-induced diabetic rats J. Pharm. Pharmacol. 48 1996 763 767
6. H.D. Yuan, J.T. Kim, S.H. Kim, and S.H. Chung Ginseng and diabetes: the evidences from in vitro, animal and human studies J. Ginseng Res. 36 2012 27 39
7. N. Karu, R. Reifen, and Z. Kerem Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor J. Agric. Food Chem. 55 2007 2824 2828
8. A.S. Attele, Y.P. Zhou, J.T. Xie, J.A. Wu, L. Zhang, L. Dey, W. Pugh, P.A. Rue, K.S. Polonsky, and C.S. Yuan Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component Diabetes 51 2002 1851 1858
9. J.H. Kim, D.H. Hahm, D.C. Yang, J.H. Kim, H.J. Lee, and I. Shim Effect of crude saponin of Korean red ginseng on high-fat diet-induced obesity in the rat J. Pharmacol. Sci. 97 2005 124 131
10. H. Lee, D. Park, and M. Yoon Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice Food Chem. Toxicol. 53 2013 402 408
11. Y. Song, J. Altarejos, M.O. Goodarzi, H. Inoue, X. Guo, R. Berdeaux, J.H. Kim, J. Goode, M. Igata, J.C. Paz, M.F. Hogan, P.K. Singh, N. Goebel, L. Vera, N. Miller, J. Cui, M.R. Jones, C. Consortium, G. Consortium, Y.D. Chen, K.D. Taylor, W.A. Hsueh, J.I. Rotter, and M. Montminy CRTC3 links catecholamine signalling to energy balance Nature 468 2010 933 939
12. L. Landsberg Feast or famine: the sympathetic nervous system response to nutrient intake Cell. Mol. Neurobiol. 26 2006 497 508
13. R. Ferrer-Lorente, C. Cabot, J.A. Fernandez-Lopez, and M. Alemany Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats Life Sci. 77 2005 2051 2058
14. Y.S. Lee, B.Y. Cha, K. Yamaguchi, S.S. Choi, T. Yonezawa, T. Teruya, K. Nagai, and J.T. Woo Effects of Korean white ginseng extracts on obesity in high-fat diet-induced obese mice Cytotechnology 62 2010 367 376
15. G.Z. Dong, E.J. Jang, S.H. Kang, I.J. Cho, S.D. Park, S.C. Kim, and Y.W. Kim Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway BMC Complement. Altern. Med. 13 2013 64
16. L. Shen, Y. Xiong, D.Q. Wang, P. Howles, J.E. Basford, J. Wang, Y.Q. Xiong, D.Y. Hui, S.C. Woods, and M. Liu Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats J. Lipid Res. 54 2013 1430 1438
17. K.T. Lee, T.W. Jung, H.J. Lee, S.G. Kim, Y.S. Shin, and W.K. Whang The antidiabetic effect of ginsenoside Rb2 via activation of AMPK Arch. Pharm. Res. 34 2011 1201 1208
18. H.M. Lee, O.H. Lee, K.J. Kim, and B.Y. Lee Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells Phytother. Res. 26 2012 1017 1022
19. H. Yuan, Y. Kim do, H.Y. Quan, S.J. Kim, M.S. Jung, and S.H. Chung Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3beta via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells Chem. Biol. Interact. 195 2012 35 42
20. S. Lee, M.S. Lee, C.T. Kim, I.H. Kim, and Y. Kim Ginsenoside Rg3 reduces lipid accumulation with AMP-Activated Protein Kinase (AMPK) activation in HepG2 cells Int. J. Mol. Sci. 13 2012 5729 5739
21. J. Moitra, M.M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M.L. Reitman, and C. Vinson Life without white fat: a transgenic mouse Genes Dev. 12 1998 3168 3181
22. M.P. Gaidhu, A. Frontini, S. Hung, K. Pistor, S. Cinti, and R.B. Ceddia Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity J. Lipid Res. 52 2011 1702 1711
23. D.A. Nadeau Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: the metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach Postgrad. Med. 125 2013 112 126